First Meeting of Chinese Medicine Development Committee convened
The newly established Chinese Medicine Development Committee (the Committee), chaired by Dr KO Wing-man, Secretary for Food and Health, held its first meeting today (March 4).
“The Committee has discussed a number of key areas on the development of Chinese medicine in Hong Kong, including personnel training and professional development, Chinese medicine services, scientific research and Chinese medicines industry development, and set the future direction and targets for its focused areas of work.” a Government spokesman said.
To enable the Committee to focus its deliberation on the direction and long-term strategy of the development of Chinese medicines in Hong Kong, two standing sub-committees will be formed under the Committee, namely Chinese Medicine Practice Sub-committee (CMPSC) and Chinese Medicines Industry Sub-committee (CMISC). The sub-committees will conduct studies and give advices and recommendations to the Committee on the development of Chinese medicine practitioners industry and the Chinese medicines industry respectively.
The terms of reference of CMPSC are to:
- study the needs for professional development of Chinese medicine practitioners and explore means for the development of Chinese medicine practice specialties, in collaboration with the Chinese Medicine Practitioners Board of the Hong Kong Chinese Medicine Council and the Steering Committee on Strategic Review on Healthcare Manpower Planning and Professional Development;
- explore means to facilitate the collaboration of Chinese medicine practitioners and medical doctors in the provision of clinical services to patients;
- explore means to expand the role of Chinese medicine in the public healthcare system; and
- study the feasibility of establishing a Chinese medicine hospital.
The terms of reference of the CMISC are to:
- explore means to safeguard and enhance the quality of Chinese medicines in Hong Kong in collaboration with the Chinese Medicines Board of the Hong Kong Chinese Medicine Council, including ways to facilitate the implementation of requirements such as the Good Manufacturing Practice and Good Clinical Practice requirements;
- set the priority areas of and facilitate researches on Chinese medicines in collaboration with the Committee on Research and Development of Chinese Medicines;
- explore means to promote Hong Kong as a centre for testing and certification of Chinese medicines; and
- promote the status of and explore business opportunities for Chinese medicines industry in Hong Kong.
The Chief Executive announced in his 2013 Policy Address the
establishment of the Committee, to give recommendations to the
Government concerning the direction and long-term strategy of the
future development of Chinese medicines in Hong Kong. The Committee,
chaired by the Secretary for Food and Health, comprises 16
non-official members from the Chinese medicine practitioners, the
Chinese medicines trade, academia and the research, healthcare
sectors and lay persons; as well as 4 ex-officio members, including
the Permanent Secretary for Food and Health (Health), Director of
Health, Commissioner for Innovation and Technology and Chief
Executive of the Hospital Authority.
Ends/Monday, March 4, 2013